Orofaciodigital syndrome 3

From WikiMD's Medical Encyclopedia

Other Names: OFD3; Oral-facial-digital syndrome type 3; OFD syndrome 3; Orofaciodigital syndrome III; Oral facial digital syndrome 3; Oral facial digital syndrome type 3; OFDS 3

Oral-facial-digital syndrome, type 3 is characterized by anomalies of the mouth, eyes and digits, associated with severe intellectual deficit.

Epidemiology[edit]

Five cases in two families have been reported (two males and three females).

Cause[edit]

The causative gene has not yet been identified.

Inheritance[edit]

Autosomal recessive inheritance, a 25% chance

Autosomal recessive inheritance has been suggested.

Signs and symptoms[edit]

Main clinical features include prominent forehead and occiput, round face with full cheeks, hypertelorism, esotropia, downslanting palpebral fissures, myoclonic twitching of the eyelids, conjugate deviation of the eyes, bifid uvula, pectus excavatum, short sternum, kyphosis, postaxial polydactyly, normal stature and severe spasticity.

For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 30%-79% of people have these symptoms

5%-29% of people have these symptoms

Diagnosis[edit]

There are no specific tests to confirm diagnosis. However, diagnosis is generally made on the basis of clinical signs and symptoms.

Treatment[edit]

Treatment is supportive based on signs and symptoms. Genetic counselling is recommended for patients and their families. Treatment may involve reconstructive surgery for facial clefts.

NIH genetic and rare disease info[edit]

Orofaciodigital syndrome 3 is a rare disease.


This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.